EP3889172
TARGETED TGF BETA INHIBITION
:
EP einkaleyfi: Þýðing ekki lögð inn:
10.2.2015:
1.5.2024:
21165709.3
:
9.2.2035
:
TARGETED TGF BETA INHIBITION
10.2.2015
1.5.2024
:
Merck Patent GmbH:
Frankfurter Strasse 250, 64293 Darmstadt, DE
:
LO, Kin-Ming:
Lexington, MA 02420, US
:
201461938048 P:
10.2.2014:
US
:
C07K 14/71, C07K 16/22, C07K 16/28, C07K 16/46, C07K 19/00